Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C

Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C

The clinical significance of mac-2 binding protein glycosylation isomer (M2BPGi) levels based on virological responses due to antiviral therapy has not been fully evaluated. We compared the change before and 24 weeks after the therapy with daclatasvir and asunaprevir (DCV+ASV) of M2BPGi levels with...

Full description

Bibliographic Details
Main Authors: Satoshi Takakusagi, Ken Sato, Kyoko Marubashi, Kazuko Kizawa, Takashi Kosone, Satoru Kakizaki, Hitoshi Takagi, Toshio Uraoka
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Biomedicines
Subjects:
mac-2 binding protein glycosylation isomer
direct acting antivirals
liver fibrosis
hepatocarcinogenesis
sustained virological response
Online Access:https://www.mdpi.com/2227-9059/9/6/660

Internet

https://www.mdpi.com/2227-9059/9/6/660

Similar Items